MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. (MPLT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MPLT · as of Jun 9, 2026
Key Statistics
Explore MapLight Therapeutics, Inc. Data
mplt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The MPLT analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $43.00, representing +45.96% upside from the current price of $29.46.
Competitors & Peers
mplt competitorsMPLT
BRTX
DWTX
EDSA
ERNA
IMRNStock Performance
Full HistoryAbout MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its p…
what is maplight therapeutics, inc. · mplt stock overview · maplight therapeutics, inc. company profile · who is maplight therapeutics, inc. ceo · mplt NASDAQ · maplight therapeutics, inc. headquarters · maplight therapeutics, inc. business segments
About Stock Overview & Key Data
MapLight Therapeutics, Inc. (MPLT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 24, 2025. As of the latest trading session, MPLT stock price is $29.46, with a market capitalization of $23.3M. The stock has returned +60.63% over the past 12 months and +67.67% year-to-date.
According to 2 Wall Street analysts, the consensus rating for MapLight Therapeutics, Inc. stock is Buy, with an average 12-month price target of $43.00. In fiscal year 2025, MapLight Therapeutics, Inc. reported revenue of — and net income of -$161.2M. For detailed data — including MapLight Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MapLight Therapeutics, Inc. (MPLT) stock price is $29.46. The stock is traded on NASDAQ under the ticker symbol MPLT. The 52-week range is $12.24 – $33.28.